Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, June 26, 2018

Sema3E/PlexinD1 Inhibition is a Therapeutic Strategy for Improving Cerebral Perfusion and Restoring Functional Loss after Stroke in Aged Rats

Now with any brains at all in stroke we would follow this up with testing in humans, but that will never occur in our lifetimes. NO STROKE LEADERSHIP AND NO STROKE STRATEGY.

Sema3E/PlexinD1 Inhibition is a Therapeutic Strategy for Improving Cerebral Perfusion and Restoring Functional Loss after Stroke in Aged Rats



Highlights

1.Sema3E as an endogenous inhibitor suppresses cerebral perfusion.
2.Unlike increasing VEGF, inhibiting Sema3E/PlexinD1 can improve the BBB integrity.
3.Sema3E suppresses both endothelial cell activity and pericytes recruitment.

Abstract

Brain tissue survival and functional recovery following ischaemic stroke greatly depend on cerebral vessel perfusion and functional collateral circulation in the ischaemic area. Semaphorin 3E (Sema3E), one of the class 3 secreted semaphorins, has been demonstrated to be a critical regulator in embryonic and postnatal vascular formation via binding to its receptor PlexinD1. However, whether Sema3E/PlexinD1 signalling is involved in poststroke neovascularization remains unknown. To determine the contribution of Sema3E/PlexinD1 signalling to poststroke recovery, aged rats (18 months) were subjected to a transient middle cerebral artery occlusion (tMCAO). We found that depletion of Sema3E/ PlexinD1 signalling with lentivirus-mediated PlexinD1-specific-shRNA improves tissue survival and functional outcome. Sema3E/PlexinD1 inhibition not only increases cortical perfusion but also ameliorates BBB damage, as determined by positron emission tomography (PET) and magnetic resonance imaging (MRI). Mechanistically, we demonstrated that Sema3E suppresses endothelial cell proliferation and angiogenic capacity. More importantly, Sema3E/ PlexinD1 signalling inhibits recruitment of pericytes by decreasing production of PDGF-BB in endothelial cells. Overall, our study revealed that inhibition of Sema3E/PlexinD1 signalling in the ischaemic penumbra, which increases both endothelial angiogenic capacity and recruitment of pericytes, contributed to functional neovascularization and BBB integrity in the aged rats. Our findings imply that Sema3E/PlexinD1 signalling is a novel therapeutic target for improving brain tissue survival and functional recovery post ischaemic stroke.

Key words

  • ischaemic stroke;
  • cerebral perfusion;
  • functional neovascularization;
  • BBB integrity;
  • endothelial cells;
  • pericytes

Abbreviation and Acronyms

  • tMCAO, transient middle cerebral artery occlusion;
  • Sema3E, Semaphorin 3E;
  • VEGF, vascular endothelial growth factor;
  • MRI, magnetic resonance imaging;
  • PET, positron emission tomography;
  • GFP, green fluorescent protein;
  • BMVECs, brain microvascular endothelial cells;
  • OGDR, oxygen glucose deprivation/reoxygenation;
  • BBB, Blood-Brain Barrier;
  • ECs, endothelial cells;
  • CNS, central nervous system

Corresponding author. Department of Neurology Union Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan 430022, China. Tel:+86-13707114863; Fax: +86-27-85726028.

Corresponding author. Yanan Li, Department of Neurology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan 430022, China.Tel:+86-15871681596;Fax: +86-27-85726028.
#
These authors contributed equally to this article.

No comments:

Post a Comment